SubsidieMeestersThe Holy Grail in Bone regeneration
GreenBone aims to revolutionize bone grafts with a synthetic Rattan wood-based implant that mimics natural bone, enhancing regeneration and targeting the spinal market by 2025.
Projectdetails
Introduction
Regeneration of large bone defects is an unmet medical need with a high socio-economic burden, affecting millions of people worldwide.
Innovation
To overcome the limitations of existing solutions for bone replacement, we developed GreenBone, our pioneering acellular synthetic bone graft obtained from a proprietary biomorphic transformation process of Rattan wood.
Features
By mimicking the chemical composition and 3D pore structure of natural human bone, we are able to provide an optimum microenvironment capable of driving:
- Inductive bone performance
- De-novo bone mineralisation response at the ectopic site
Market Strategy
With the EIC accelerator grant, we aim to disrupt the bone graft market by introducing the first technologically advanced spinal implant that combines the needed mechanical strength with enhanced regenerative capacity.
Goals
We aim to bring our product to the spinal market segment in 2025, with the following objectives:
- Reach 10% market share by 2030
- Grow our company team to more than 40 skilled professionals
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.458.128 |
| Totale projectbegroting | € 3.511.612 |
Tijdlijn
| Startdatum | 1-9-2022 |
| Einddatum | 31-8-2025 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- GREENBONE ORTHO SPApenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
A new cardioprotective drug for acute treatment of myocardial infarctionResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Clear, scalable and scientific framework to measure terrestrial biodiversity3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value. | EIC Accelerator | € 2.252.714 | 2024 | Details |
Novel and Scalable microbial products for REgenerative agricultureN-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data SecurityQuside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors. | EIC Accelerator | € 2.499.999 | 2024 | Details |
A new cardioprotective drug for acute treatment of myocardial infarction
ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.
Clear, scalable and scientific framework to measure terrestrial biodiversity
3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value.
Novel and Scalable microbial products for REgenerative agriculture
N-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency.
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data Security
Quside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
BioBone: Bioactive Hydrogel-based Implants to Induce Bone RegenerationThe project aims to enhance bone regeneration after tumor resection by developing 3D-printed porous titanium implants integrated with bioactive materials, improving patient outcomes and reducing complications. | ERC POC | € 150.000 | 2024 | Details |
Regenerative Stenting for Osteoporotic Vertebral Fracture RepairRESTORE aims to revolutionize osteoporotic vertebral fracture treatment by using 3D-printed biodegradable stents and thermoresponsive hydrogels for personalized bone regeneration and repair. | ERC COG | € 2.039.473 | 2024 | Details |
A 3D-printable biomimetic bone regeneration materialPRIOBONE aims to validate a novel 3D-printable, bone-mimetic material for critical-size bone defects, offering a customizable, cost-effective solution to improve healing outcomes. | ERC POC | € 150.000 | 2024 | Details |
Self-feeding implants to improve and accelerate tissue healing using nutritional nanoparticlesThe NutriBone project aims to develop a patented self-feeding bone implant that enhances long-term viability and reduces failure rates for large bone defects through glycogen-based glucose release. | ERC POC | € 150.000 | 2024 | Details |
BioBone: Bioactive Hydrogel-based Implants to Induce Bone Regeneration
The project aims to enhance bone regeneration after tumor resection by developing 3D-printed porous titanium implants integrated with bioactive materials, improving patient outcomes and reducing complications.
Regenerative Stenting for Osteoporotic Vertebral Fracture Repair
RESTORE aims to revolutionize osteoporotic vertebral fracture treatment by using 3D-printed biodegradable stents and thermoresponsive hydrogels for personalized bone regeneration and repair.
A 3D-printable biomimetic bone regeneration material
PRIOBONE aims to validate a novel 3D-printable, bone-mimetic material for critical-size bone defects, offering a customizable, cost-effective solution to improve healing outcomes.
Self-feeding implants to improve and accelerate tissue healing using nutritional nanoparticles
The NutriBone project aims to develop a patented self-feeding bone implant that enhances long-term viability and reduces failure rates for large bone defects through glycogen-based glucose release.